Doxylamine Succinate And Pyridoxine Hydrochloride Tablet, Delayed Release
Product Images NDC 49884-186

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Doxylamine Succinate And Pyridoxine Hydrochloride (NDC 49884-186). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxylamine Succinate And Pyridoxine Hydrochloride Delayed-release Tablets (Doxylamine Succinate And Pyridoxine Hydrochloride 1)

Doxylamine Succinate And Pyridoxine Hydrochloride Delayed-release Tablets (Doxylamine Succinate And Pyridoxine Hydrochloride  1)
Chemical structure diagram showing two molecular structures side by side. This image represents the chemical structures of the active ingredients doxylamine succinate and pyridoxine hydrochloride in the Doxylamine Succinate and Pyridoxine Hydrochloride delayed release tablets.*
FDA Label Image

Doxylamine Succinate And Pyridoxine Hydrochloride Delayed-release Tablets (Doxylamine Succinate And Pyridoxine Hydrochloride 2)

Doxylamine Succinate And Pyridoxine Hydrochloride Delayed-release Tablets (Doxylamine Succinate And Pyridoxine Hydrochloride  2)
Chemical structure diagram showing the molecular structure of Pyridoxine Hydrochloride, an active ingredient in Doxylamine Succinate and Pyridoxine Hydrochloride delayed-release tablets 10 mg/10 mg.*
FDA Label Image

Doxylamine Succinate And Pyridoxine Hydrochloride Delayed-release Tablets (Doxylamine Succinate And Pyridoxine Hydrochloride 3)

Doxylamine Succinate And Pyridoxine Hydrochloride Delayed-release Tablets (Doxylamine Succinate And Pyridoxine Hydrochloride  3)
Label for Doxylamine Succinate and Pyridoxine Hydrochloride Delayed-Release Tablets 10 mg/10 mg by Par Pharmaceutical. The label indicates film-coated delayed-release tablets, dosage instructions, storage conditions, and contains a warning to swallow tablets whole. The package contains 100 tablets for oral use and is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.